37 research outputs found

    OncoLog Volume 50, Number 06, June 2005

    Get PDF
    Teen-Savvy Smoking Prevention Considering Prophylactic Surgery, Part II House Call: From Patient to Patient: Real-World Coping Tips Enrolling Patients in Prevention Trials, by Therese B. Bevers, MD, Associate Professor, Department of Clinical Cancer Preventionhttps://openworks.mdanderson.org/oncolog/1136/thumbnail.jp

    OncoLog Volume 51, Number 04, April 2006

    Get PDF
    Redefining Unresectable Disease: Strategies for Treating Liver Metastases from Colorectal Cancer Cancer Screening Guidelines Revised: One on One with Dr. Therese Bevers House Call; What Is Breast Self-Awareness ? DiaLog: The Revolutionary Cervical Cancer Vaccine, by Therese B. Bevers, MD, Medical Director, Cancer Prevention Centerhttps://openworks.mdanderson.org/oncolog/1180/thumbnail.jp

    Chemoprevention for Breast Cancer

    Get PDF

    Validity assessment of the Breast Cancer Risk Reduction Health Belief scale.

    Get PDF
    BACKGROUND: : Women at increased risk of breast cancer (BC) are not widely accepting of chemopreventive interventions, and ethnic minorities are underrepresented in related trials. Furthermore, there is no validated instrument to assess the health-seeking behavior of these women with respect to these interventions. METHODS: : By using constructs from the Health Belief Model, the authors developed and refined, based on pilot data, the Breast Cancer Risk Reduction Health Belief (BCRRHB) scale using a population of 265 women at increased risk of BC who were largely medically underserved, of low socioeconomic status (SES), and ethnic minorities. Construct validity was assessed using principal components analysis with oblique rotation to extract factors, and generate and interpret summary scales. Internal consistency was determined using Cronbach alpha coefficients. RESULTS: : Test-retest reliability for the pilot and final data was calculated to be r = 0.85. Principal components analysis yielded 16 components that explained 64% of the total variance, with communalities ranging from 0.50-0.75. Cronbach alpha coefficients for the extracted factors ranged from 0.45-0.77. CONCLUSIONS: : Evidence suggests that the BCRRHB yields reliable and valid data that allows for the identification of barriers and enhancing factors associated with use of breast cancer chemoprevention in the study population. These findings allow for tailoring treatment plans and intervention strategies to the individual. Future research is needed to validate the scale for use in other female populations. Cancer 2009. (c) 2009 American Cancer Society

    OncoLog Volume 43, Number 01, January 1998

    Get PDF
    Taking Mammography on the Road Reassurance and Education Foster Rehabilitation After Colorectal Surgery Protocols: Protocols focus on chemoprevention, improving preoperative radiotherapy, and treating advance-stage colorectal cancer Sphincter-Preserving Surgery Improves Outcome for Patients with Rectal Cancer House Call: Stopping Cancer Before It Occurs: Spell P-r-e-v-e-n-t-i-o-n Dialog: Reaching Out and In by Therese Bevers, MD, Cancer Prevention Center Director Protocols: Protocols focus on chemoprevention, improving preoperative radiotherapy, and treating advance-stage colorectal cancerhttps://openworks.mdanderson.org/oncolog/1057/thumbnail.jp

    CT screening for lung cancer

    No full text

    Ultrasound for the screening of breast cancer

    No full text

    Alcohol and cancer incidence in women

    No full text
    corecore